Profit Or Loss [Abstract]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	48 512 BGN	—	—	—	—	—	—	—	43 146 BGN	—	—	—
Other income	—	—	74,000 BGN	—	—	—	—	—	—	—	721,000 BGN	—	—	—
Decrease (increase) in inventories of finished goods and work in progress	—	—	233,000 BGN	—	—	—	—	—	—	—	1 896 BGN	—	—	—
Raw materials and consumables used	—	—	12 172 BGN	—	—	—	—	—	—	—	13 954 BGN	—	—	—
Employee benefits expense	—	—	7 333 BGN	—	—	—	—	—	—	—	6 023 BGN	—	—	—
Depreciation and amortisation expense	—	—	2 809 BGN	—	—	—	—	—	—	—	3 568 BGN	—	—	—
Other expenses, by nature	—	—	899,000 BGN	—	—	—	—	—	—	—	456,000 BGN	—	—	—
Profit (loss) before tax	—	—	3 868 BGN	—	—	—	—	—	—	—	3 132 BGN	—	—	—
Tax expense (income)	—	—	470,000 BGN	—	—	—	—	—	—	—	342,000 BGN	—	—	—
Profit (loss)	- BGN	- BGN	3 398 BGN	- BGN	- BGN	3 398 BGN	3 398 BGN	- BGN	- BGN	- BGN	2 790 BGN	2 790 BGN	2 790 BGN	- BGN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	3 398 BGN	—	—	—	—	—	—	—	2 790 BGN	—	—	—
Profit (loss), attributable to non-controlling interests	—	—	- BGN	—	—	—	—	—	—	—	- BGN	—	—	—
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	0.0400	—	—	—	—	—	—	—	0.0300	—	—	—